
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2223677-63-0 |
| Catalog No. | 2A-3181758 |
| Chinese Name | (S,E)-N-(4-((3,4-二氯苯基)氨基)-7-((四氢呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲氨基)丁-2- 烯酰胺(阿法替尼杂质) |
| Molecular Formula | C24H25O3N5Cl2 |
| Molecular Weight | 502.4 |
| Storage Condition | 2-8°C, protect from light |
| PubChem ID | 434047697 |
| MDL Number | MFCD34471986 |
| SMILES | CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC1CCOC1 |
| InChI | InChI=1S/C24H25Cl2N5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-18(25)19(26)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1 |
| InChI Key | GMLBQFFEIVQHIS-CWDCEQMOSA-N |
| Transport Info | Product name: (SE)-N-(4-((34-dichlorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (afatinib impurity) |
| Related Products in Analytical Standards | ||
|---|---|---|
| Dabigatran Etexilate iMpurity C5 | 1416446-45-1 | 2A-3181726 |
| Dabigatran Etexilate iMpurity C4 | 1416446-43-9 | 2A-3181727 |
| Dabigatran Etexilate iMpurity 1 | 1610758-19-4 | 2A-3181728 |
| Dabigatran iMpurity E | 1456889-80-7 | 2A-3181729 |
| Edoxaban impurity 9/N1-(5-Chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(methylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide | 740794-83-6 | 2A-3181731 |
| Afatinib IMpurity SF | 2223677-62-9 | 2A-3181759 |
| Afatinib IMpurity J | 1456696-14-2 | 2A-3181760 |
| Afatinib impurity 9 | 2170273-17-1 | 2A-3181761 |
| Afatinib impurity 11/Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib | 2223677-58-3 | 2A-3181762 |
| Afatinib IMpurity I | 1637254-93-3 | 2A-3181763 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA